← Leaderboards
Mark L Tykocinski
University Of Pennsylvania
$7,389,510
Attributed
$7,389,510
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$7,389,510 · 4
By mechanism
R01$7,268,550 · 3
R03$120,960 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- E Michael Ostap$23,710,653
- Andrew B. Dancis$9,246,751
- Ben E. Black$15,469,500
- Shelley L Berger$32,851,390
- Yale E Goldman$23,621,697
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseT LymphocyteHuman SubjectClinical ResearchAntigen Presenting CellLeukocyte Activation /TransformationImmunomodulatorsCd AntigensRecombinant ProteinsProtein EngineeringAutoimmunityTransfectionBiotechnologyProtein Structure FunctionImmunoregulationT Cell ReceptorGlycoproteinsGene ExpressionCd95 MoleculeImmunosuppressionNeoplasm /Cancer ImmunotherapyCytotoxic T LymphocyteHistocompatibility AntigensImmunosuppressive
Grant awards (23)
CELLULAR CANCER VACCINES$334,387
R01 · FY2007 · CA · contact PI
Engineering Artifical Veto Cells$386,938
R01 · FY2006 · AI · contact PI
CELLULAR CANCER VACCINES$344,375
R01 · FY2006 · CA · contact PI
PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR$440,982
R01 · FY2005 · AI
Engineering Artifical Veto Cells$396,250
R01 · FY2005 · AI
CELLULAR CANCER VACCINES$352,663
R01 · FY2005 · CA
Placental Protein 14 as a Lectin-Like Immunomodulator$40,320
R03 · FY2005 · TW
PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR$428,139
R01 · FY2004 · AI
Engineering Artifical Veto Cells$396,250
R01 · FY2004 · AI
CELLULAR CANCER VACCINES$352,663
R01 · FY2004 · CA
Placental Protein 14 as a Lectin-Like Immunomodulator$40,320
R03 · FY2004 · TW
PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR$415,668
R01 · FY2003 · AI
Engineering Artifical Veto Cells$396,250
R01 · FY2003 · AI
CELLULAR CANCER VACCINES$352,663
R01 · FY2003 · CA
Placental Protein 14 as a Lectin-Like Immunomodulator$40,320
R03 · FY2003 · TW
PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR$403,562
R01 · FY2002 · AI
Engineering Artifical Veto Cells$396,250
R01 · FY2002 · AI
PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR$391,806
R01 · FY2001 · AI
ENGINEERING ARTIFICIAL VETO CELLS$303,233
R01 · FY2001 · AI
CELLULAR CANCER VACCINES--GPI PROTEIN TRANSFER$273,340
R01 · FY2001 · CA
HEMATOPOIETIC PP14--AN ANTIINFLAMMATORY CYTOKINE$341,332
R01 · FY2000 · AI
ENGINEERING ARTIFICIAL VETO CELLS$295,479
R01 · FY2000 · AI
CELLULAR CANCER VACCINES--GPI PROTEIN TRANSFER$266,320
R01 · FY2000 · CA